Analyst Upgrades

• General Growth (GGP) to outperform from neutral at Credit Suisse.
• PPL Corp. (PPL) to outperform from market perform at FBR Capital.
• Hudson City Bancorp (HCBK) to neutral from reduce at Nomura.
• Hologic (HOLX) to conviction buy from buy at Goldman.
• Cognex (CGNX) to overweight from neutral at Piper Jaffray.
• Buckeye Partners (BPL) to outperform from market perform at Wells Fargo.
• Ericsson (ERIC) and Health Care REIT (HCN) to buy from neutral and Olin (OLN) to neutral from sell at UBS.
• Nalco (NLC) to overweight from neutral at JPMorgan.
• Watts Water (WTS) to buy from hold at BB&T.
• McDermott (MDR) to buy from neutral at Pritchard.

Continue reading Analyst Calls: AMTD, BPL, BX, ERIC, FTE, GGP, HCBK, HCN, NE, PPL, TUP ...

Analyst Calls: AMTD, BPL, BX, ERIC, FTE, GGP, HCBK, HCN, NE, PPL, TUP ... originally appeared on BloggingStocks on Thu, 03 Mar 2011 11:20:00 EST. Please see our terms for use of feeds.

Analyst Upgrades

• Applied Materials (AMAT) to overweight from neutral at Piper Jaffray.
• Air Products (APD) to buy from hold at Citigroup.
• Youku.com (YOKU) and Pinnacle West (PNW) to buy from neutral at Goldman.
• Stryker (SYK) and Zimmer (ZMH) to buy from neutral at UBS.
• Zions Bancorp (ZION) to outperform from neutral at Macquarie.
• Alnylam (ALNY) to buy from hold at Needham.
• AK Steel (AKS) to buy from hold at KeyBanc.

Continue reading Analyst Calls: AEP, AKS, AMAT, EZCH, FRX, LOPE, MYGN, PNW, ZION ...

Analyst Calls: AEP, AKS, AMAT, EZCH, FRX, LOPE, MYGN, PNW, ZION ... originally appeared on BloggingStocks on Wed, 23 Feb 2011 11:40:00 EST. Please see our terms for use of feeds.

Analyst Upgrades

• Micron (MU) to buy from neutral at UBS.
• Baker Hughes (BHI) to outperform from market perform at BMO Capital.
• PDL BioPharma (PDLI) to outperform from sector perform at RBC Capital.
• Fluor (FLR) and Rush Enterprises (RUSHA) to buy from neutral at BofA/Merrill.
• Camden Property (CPT) to outperform from neutral at Macquarie.
• Pinnacle Financial (PNFP) to buy from hold at Wunderlich.
• Linear Technology (LLTC) to neutral from reduce at Nomura.
• Hologic (HOLX) and Illumina (ILMN) to buy from hold at Citigroup.
• F5 Networks (FFIV) to buy from neutral at Gleacher.

Continue reading Analyst Calls: ALTR, BHI, CL, CLX, FFIV, GS, HCBK, LLTC, PG, STT, TYC ...

Analyst Calls: ALTR, BHI, CL, CLX, FFIV, GS, HCBK, LLTC, PG, STT, TYC ... originally appeared on BloggingStocks on Thu, 20 Jan 2011 12:00:00 EST. Please see our terms for use of feeds.

MGM Mirage (MGM) closed at $10.56. MGM says Dubai World's financial troubles wouldn't affect its CityCenter project. MGM December and January option implied volatility of 70 is below 26-week average of 89, according to Track Data, suggesting decreasing price movement.

Hologic (HOLX), a digital mammography company, closed at $14.42. HOLX will be displaying its diagnostic imaging products at the Radiological Society of North America (RSNA) 2009 Annual Meeting today. December option implied volatility is at 43, January is at 42; below its 26-week average of 50, according to Track Data, suggesting decreasing price movement.

Option Update is provided by Stock Specialist Paul Foster of theflyonthewall.com.

Options update: MGM Mirage volatility low at 70 originally appeared on BloggingStocks on Mon, 30 Nov 2009 08:20:00 EST. Please see our terms for use of feeds.

Hologic (HOLX) surprisingly revises Q1 forecast higher originally appeared on BloggingStocks on Mon, 12 Jan 2009 13:31:00 EST. Please see our terms for use of feeds.

MOST NOTEWORTHY:

• Friedman Billings downgraded American Eagle (NYSE: AEO) to Underperform from Market Perform citing slowing top-line growth, difficult macro-environment, and the challenging women's category.
  
• Soleil cut Hologic (NASDAQ: HOLX) to Hold from Buy as it believes the cancellation of the FDA Radiological Devices Panel means a further delay in the tomosynthesis pre-market approval application.
  
• ABN downgraded shares of British Airways (Other OTC: BAIRY) to Sell from Hold as it believes the recent rally in the face of higher oil prices is unjustified. Shares were also lowered at Deutsche Bank to Sell from Buy as it believes the company may not be able to raise ticket prices enough to offset higher fuel costs.

• ArthroCare (NASDAQ: ARTC) was cut to Accumulate from Buy at ThinkPanmure.
  
• ING downgraded J Sainsbury (Other OTC: JSAIY) to Sell from Hold.
  
• RBC Capital downgraded Ceragon Networks (NASDAQ: CRNT) to Sector Perform from outperform.

Analyst downgrades: AEO, HOLX and BAIRY originally appeared on BloggingStocks on Mon, 19 May 2008 11:35:00 EST. Please see our terms for use of feeds.

Hologic (NASDAQ: HOLX), a medical imaging company, is recently trading down 71 cents to $20.22 in pre-open trading.

Soleil says: "downgrading HOLX from Buy to Hold following our confirmation from the FDA that the tentative date for Radiological Devices Panel (8.12.08) has been canceled-an action which reads negative for HOLX."

HOLX over all option implied volatility of 46 is above its 26-week average of 43 according to Track Data, suggesting larger price uncertainty.

Option Update is provided by Stock Specialist Paul Foster of theflyonthewall.com

Option Update: Hologic (HOLX) volatility at 43 as shares near 20-month low originally appeared on BloggingStocks on Mon, 19 May 2008 10:48:00 EST. Please see our terms for use of feeds.

Demographic, education trends are in Hologic's (HOLX) favor originally appeared on BloggingStocks on Fri, 04 Jan 2008 16:30:00 EST. Please see our terms for use of feeds.

For 25 years, Steven Halpern, editor of TheStockAdvisors.com, has surveyed the leading financial newsletter advisors asking for their favorite stocks for the coming year. This article is one of 100+ ideas in the Best Stocks for 2008 report.

"Hologic, Inc. (NASDAQ: HOLX), my top more conservative idea for 2008, is fast becoming the 'Amazon' of women's health care," says Benson George, editor of Top Stocks Insights.

"The company, which specializes in diagnostic and medical imaging systems, bought complementary Cytyc Corp. in October, making Hologic the warrior of reckoning in the growing women's health market.

Hologic develops products for mammography and breast care, osteoporosis assessment and general use radiology. Cytyc's products cover a range of cancers and women's health concerns, including cervical cancer screening, prenatal diagnostics and partial breast radiation therapy.

"The combined company offers a broad and diversified mix of products and services focused only on women's health -- a multi-billion-dollar market growing 16% compounded annually.

Continue reading Best Stocks for 2008: Hologic (HOLX) targets women's health care

Best Stocks for 2008: Hologic (HOLX) targets women's health care originally appeared on BloggingStocks on Sun, 23 Dec 2007 12:40:00 EST. Please see our terms for use of feeds.

Activision, Inc. (NASDAQ: ATVI): Revised it's outlook upward. Shares moved up to $27.98 from 52-week low of $16.05.

Hologic, Inc. (NASDAQ: HOLX): Company is to be added to the Nasdaq 100. Traded up to $69.75 from 52-week low of $45.88.

Archer Daniels Midland Company (NYSE: ADM): The company is still moving up on strength of legislation of new law to increase ethanol production. It hit $43.37 up from 52-week low of $30.20.

Tribune Company (NYSEL: TRB): Deal to take company private finally closes. Up to $34 from 52-week low of $22.78.

Douglas A. McIntyre is an editor at 247wallst.com.

The 52-week high club originally appeared on BloggingStocks on Thu, 20 Dec 2007 18:35:00 EST. Please see our terms for use of feeds.

Hologic (NASDAQ: HOLX) develops, manufactures and supplies diagnostic, medical imaging and radiology systems. The Radiological Society of North America (RSNA) 2007 Annual Meeting is this week in Chicago at McCormick Place. CIBC says "HOLX maintains Strong lead over competition." HOLX overall option implied volatility of 38 is near its 26-week average according to Track Data, suggesting non-directional risk.

Daily Options Update is provided by Stock Specialist Paul Foster of theflyonthewall.com

Option update 11-28-08: Hologic (HOLX) shows technology at radiology conference originally appeared on BloggingStocks on Wed, 28 Nov 2007 14:41:00 EST. Please see our terms for use of feeds.

• RBC Capital Markets started Genomic Health Inc (NASDAQ: GHDX) with an Underperform rating, with a $17 target. The firm views shares as fairly valued and believes competitive noise and FDA concerns will weigh on shares.

• HSBC started Intercontinental Hotels (NYSE: IHG) with an Overweight rating, believing asset sales and stronger than expected room growth could prove near-term positive catalysts.

• Soliel started both Continental Airlines (NYSE: CAL) and ExpressJet Holdings Inc (NYSE: XJT) with Sell ratings.

• William Blair started Alexion Pharmaceuticals (NASDAQ: ALXN) with an Outperform rating. They believe Alexion's lead compound, Soliris, is the key driver of shareholder value, and they believe the company is well positioned to receive final FDA approval.

• Bear Stearns initiated Baldor Electric Company (NYSE: BEZ) with an Outperform rating.

• RBC initiated Hologic, Inc (NASDAQ: HOLX) with an Outperform rating.

• Citigroup started GMarket Inc (NASDAQ: GMKT) with a Sell rating and $18 target, citing valuation.

• Drew Industries, Inc (NYSE: DW) was initiated with a Buy rating and $35 target at Ferris Baker Watts.

Analyst initiations 3-07-07: Continental Arilines & Intercontinental Hotels were initiated today originally appeared on BloggingStocks on Wed, 07 Mar 2007 11:30:00 EST. Please see our terms for use of feeds.